Fukumoto Shinya

写真a

Search Institutional Repository


Title

Associate Professor

Laboratory location

Abeno Campus

Mail Address

E-mail address

Degree 【 display / non-display

  • Osaka City University -  M.D., Ph.D.

Research Areas 【 display / non-display

Epidemiology and preventive medicine, Metabolomics, Cardiovascular medicine, Kidney internal medicine

Research Interests 【 display / non-display

Preventive medicine, Epidemiology, Biomarker, artificial intelligence (AI), diabetes mellitus, angiogenesis, atheroscrelosis, diet therapy, cohort study, NAFLD, obesity

Research Career 【 display / non-display

  • Development of novel angiogenic treatments for ASO

    (Collaboration in Japan) Project Year :

    2001.04
    -
    2005.03

    Keyword in research subject:  angiogenic, bone marrow cell, progenitor cell

Association Memberships 【 display / non-display

  • Japanese society of Diabetes

  • Japan Atherosclerosis Sociry

Current Career 【 display / non-display

  • Osaka City University   Graduate School of Medicine   Clinical Medicine Course   Associate Professor  

  • Osaka City University  

  • Osaka City University  

Career 【 display / non-display

  • 1998.01
    -
    1999.11

    Harvard School of Public Health   Cardiovascular lab.  

  • 1999.12
    -
    2001.03

    Brigham and Women's Hospital / Harvard Medical School   Cardiovascular lab.  

  • 2001.04
    -
    2003.09

    Osaka City University  

  • 2003.10
    -
    2010.09

    Osaka City University  

  • 2010.10
    -
    2014.03

    Osaka City University  

display all >>

Graduate School 【 display / non-display

  • 1993.04
    -
    1997.03

    Osaka City University  Graduate School, Division of Medicine 

Graduating School 【 display / non-display

  • 1985.04
    -
    1991.03

    Osaka City University   Faculty of Medicine   Medical

 

Published Papers 【 display / non-display

  • SARS-CoV-2-induced humoral immunity through B cell epitope analysis in COVID-19 infected individuals

    Yoshida Shota, Ono Chikako, Hayashi Hiroki, Fukumoto Shinya, Shiraishi Satoshi, Tomono Kazunori, Arase Hisashi, Matsuura Yoshiharu, Nakagami Hironori

    SCIENTIFIC REPORTS  11 ( 1 ) 5934 2021.03  [Refereed]

    DOI PubMed

  • Prevalence and risk factors of functional constipation in the Rome IV criteria during a medical check-up in Japan

    Otani Koji, Watanabe Toshio, Takahashi Kanae, Nadatani Yuji, Fukunaga Shusei, Hosomi Shuhei, Tanaka Fumio, Kamata Noriko, Taira Koichi, Nagami Yasuaki, Kimura Tatsuo, Fukumoto Shinya, Kawada Norifumi, Fujiwara Yasuhiro

    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY  2021.02  [Refereed]

    DOI PubMed

  • Albuminuria rather than glomerular filtration rate is associated with vascular endothelial function in patients with type 2 diabetes

    Kakutani Yoshinori, Morioka Tomoaki, Mori Katsuhito, Yamazaki Yuko, Ochi Akinobu, Kurajoh Masafumi, Fukumoto Shinya, Shioi Atsushi, Shoji Tetsuo, Inaba Masaaki, Emoto Masanori

    JOURNAL OF DIABETES AND ITS COMPLICATIONS  34 ( 12 ) 107702 2020.12  [Refereed]

    DOI PubMed

  • Eosinophilic esophagitis and asymptomatic esophageal eosinophilia display similar immunohistological profiles

    Kitamura Hiroyuki, Fukumoto Shinya, Watanabe Toshio, Kawada Norifumi, Fujiwara Yasuhiro, Tanaka Fumio, Nadatani Yuji, Otani Koji, Hosomi Shuhei, Kamata Noriko, Taira Koichi, Nagami Yasuaki, Tanigawa Tetsuya

    Journal of Clinical Biochemistry and Nutrition  2020.11  [Refereed]

     View Summary

    <p>Patients with asymptomatic esophageal eosinophilia (aEE) do not exhibit clinical symptoms because of esophageal dysfunction, although they have endoscopic and histological findings similar to those of eosinophilic esophagitis (EoE). The cause of the symptoms and the differences between aEE and EoE are unclear. The aim of this study is to determine whether aEE and EoE are same disease entities by comparing immune-related tissue biomarkers using immunohistological staining. Esophageal biopsy specimens from 61 patients, including 18 with aEE and 43 with EoE, were analyzed. Immunofluorescence staining was performed to quantify the immune-related tissue biomarkers such as major basic protein, eosinophil-derived neurotoxin, eotaxin-3, and immunoglobulin G4. Data are presented as median (interquartile range). There were no significant differences in clinical, endoscopic, or histological features, between patients with aEE and EoE, with the exception of body mass index. There were no significant differences in all immune-related tissue biomarkers between both groups. In conclusions, EoE and aEE displayed similar immunohistological profiles. Hence, they may be similar disease entities with some common pathogenic mechanisms. Our findings suggest that patients with aEE also have histopathological esophageal inflammation.</p>

    DOI CiNii

  • Utility of Kyoto Classification of Gastritis in subjects with a high-negative titer of anti-Helicobacter pylori antibody during a medical check-up(和訳中)

    Otani Koji, Watanabe Toshio, Kosaka Satoshi, Matsumoto Yuji, Nakata Akinobu, Nadatani Yuji, Fukunaga Shusei, Hosomi Shuhei, Tanaka Fumio, Kamata Noriko, Taira Koichi, Nagami Yasuaki, Tanigawa Tetsuya, Kimura Tatsuo, Fukumoto Shinya, Kawada Norifumi, Fujiwara Yasuhiro

    (一社)日本酸化ストレス学会 Journal of Clinical Biochemistry and Nutrition  67 ( 3 ) 317 - 322 2020.11  [Refereed]

display all >>

Review Papers (Misc) 【 display / non-display

display all >>

Conference Activities & Talks 【 display / non-display

display all >>

 

Other educational activity and Special note 【 display / non-display

  • Contribution to internationalization

    (2020)

  • Contribution to FD activities

    (2020)

  • Contribution to University-wide Cross-training program

    (2020)

  • Extra-Curricular Activities

    (2020)

  • Extra-Curricular Activities

    (2019)

display all >>

 

Social Contribution 【 display / non-display

  • Avoiding amputations - development of nano-scaffold significantly increases effectiveness of angiogenesis treatment

    Role : Interviewee

     Audience : Researchesrs, General, Company, Media 

    2012.05
     
     

    Sponsor, Organizer, Publisher : nanowerk News  nanowerk News 

  • Avoiding amputations - development of nano-scaffold significantly increases effectiveness of angiogenesis treatment

    Role : Interviewee

     Audience : Researchesrs, General, Scientific organization, Company, Media 

    2012.05
     
     

    Sponsor, Organizer, Publisher : nano academia  nano academia 

  • Nanotech used to reduce amputation risk in diseased mice

    Role : Interviewee

     Audience : General, Media 

    2012.04
     
     

    Sponsor, Organizer, Publisher : The Japan Times  The Japan Times